Format

Send to

Choose Destination
Dermatology. 2017;233(2-3):141-144. doi: 10.1159/000471799. Epub 2017 May 5.

Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study.

Author information

1
Department of Dermatology, University of Cincinnati, Cincinnati, OH, USA.

Abstract

Prior studies have demonstrated that spironolactone is an effective second-line treatment option for postadolescent acne, but has notable side effects. Data are, however, limited. We therefore present a 4-year retrospective study evaluating 291.5 patient-years of spironolactone for the treatment of acne. Our results showed that 86% of patients improved on spironolactone therapy. Further, patients who improved showed minimal side effects, supporting recent evidence that spironolactone is a safe option for acne treatment with a low risk of short-term adverse effects such as hyperkalemia. It is suggested that our study encourages consideration of spironolactone for postadolescent acne.

KEYWORDS:

Acne; Female; Postadolescent acne

PMID:
28472793
DOI:
10.1159/000471799
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center